Infinity Pharmaceuticals, Inc. Restructuring and Related Cost, Expected Cost Remaining
Infinity Pharmaceuticals, Inc. had Restructuring and Related Cost, Expected Cost Remaining of $0 as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1 · last filed 2018-03-15
- 2017-12-31: Restructuring and Related Cost, Expected Cost Remaining $0.00.
- 2017-09-30: Restructuring and Related Cost, Expected Cost Remaining $0.00.
| Period end | Restructuring and Related Cost, Expected Cost Remaining |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 |